Updated Jul 16, 2026
Kihara James has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $699K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-29 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 11.4K | $26.08 | $298K |
| 2026-05-27 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 5.4K | $21.18 | $114K |
| 2026-05-05 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 1.3K | $21.79 | $29K |
| 2026-05-05 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 2.6K | — | |
| 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 1.0K | $22.20 | $23K |
| 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 2.0K | — | |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 12 | $21.73 | $261 |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 1.1K | $21.65 | $24K |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 2.1K | — | |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 833 | $21.47 | $18K |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 1.6K | — | |
| 2025-05-16 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 2.0K | $20.00 | $40K |
| 2025-05-16 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 2.0K | $25.00 | $50K |
| 2025-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 1.3K | $14.60 | $19K |
| 2025-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 2.6K | — | |
| 2025-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale | 1.0K | $14.82 | $15K |
| 2025-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise | 2.0K | — | |
| 2024-11-19 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 4.1K | $16.81 | $68K |
| 2024-11-19 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 4.0K | — | |
| 2024-11-19 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 4.0K | — |
Kihara James is a corporate insider — currently tracked as Insider of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 12 open-market sales ($699K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kihara James profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.